Survey of recent clinical trials of the prevention and immunointervention of type 1 diabetes mellitus;Übersicht über aktuelle Studien zur Prävention und Immunintervention des Diabetes mellitus Typ 1

Deutsche Medizinische Wochenschrift

Volumn 135, Issue 8, 2010, Pages 350-354

  Boerschmann, H ^a   Walter, M ^a,b   Achenbach, P ^a   Ziegler, A G ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Klinikum Schwabing   (Germany)

Author keywords

Immunointervention; Immunoprevention; Intervention trial; Type 1 diabetes mellitus

Indexed keywords

ALUMINUM HYDROXIDE; ALUMINUM POTASSIUM SULFATE; AUTOANTIBODY; C PEPTIDE; DIAMYD; GLUTAMATE DECARBOXYLASE 65; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INSULIN; INTERLEUKIN 10; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ANTIRHEUMATIC AGENT; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT PROTEIN; VACCINE;

AUTOIMMUNITY; BLOOD GLUCOSE MONITORING; CELL FUNCTION; CELLULAR IMMUNITY; CLINICAL TRIAL; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINE RELEASE; DRUG EFFICACY; GENETIC PREDISPOSITION; GENETIC RISK; GLUCOSE METABOLISM; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPERGLYCEMIA; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; INFECTION SENSITIVITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; INTERVENTION STUDY; MEDICAL ETHICS; PANCREAS ISLET; PATHOGENESIS; PATIENT SAFETY; POLYDIPSIA; POLYURIA; PREDICTION; PRIMARY PREVENTION; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; REVIEW; SCREENING; SECONDARY PREVENTION; VACCINATION; WEIGHT REDUCTION; BLOOD; BLOOD TRANSFUSION; CHILD; DISEASE COURSE; DRUG ANTAGONISM; FETUS BLOOD; GENETICS; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METABOLISM; ORAL DRUG ADMINISTRATION; PANCREAS ISLET BETA CELL; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TRANSPLANTATION;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANTIRHEUMATIC AGENTS; AUTOANTIBODIES; BLOOD GLUCOSE; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FETAL BLOOD; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN-SECRETING CELLS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; VACCINES;

EID: 77249124568     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0030-1249169     Document Type: Review

References (48)

1. Achenbach P, Barker J, Bonifacio E. Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization. Curr Diab Rep 2008 8 87-93
2. Achenbach P, Bonifacio E, Koczwara K, Ziegler A G. Natural History of Type 1 Diabetes. Diabetes 2005 54 Suppl. 2 S25-S31
3. Aly T A., Ide A, Barker J M., et al. HLA genotype and haplotype sharing determine extremely high risk of early childhood type 1 diabetes. Proc Natl Acad Sci USA 2006 103 14074-14079
4. Atkinson M A., Eisenbarth G S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001 358 221-229
5. Bach J -F. Insulin-dependent diabetes mellitus is an autoimmune disease. Endocrine Rev 1994 15 516-542
6. Barker J M., Barriga K J., Yu L, et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 2004 89 3896-3902
7. Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen J H., Dinarello C A., Svenson M. Cytotoxicity of human pI7 interleukin-1 for pancreatic islets of Langerhans. Science 1986 232 1545-1547
8. Beilhack G F., Scheffold Y C., Weissman I L., et al. Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Diabetes 2003 52 59-68
9. Bonifacio E, Hummel M, Walter M, Schmid S, Ziegler A G. IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high riskfor type 1 diabetes. Diabetes Care 2004 27 2695-2700
10. Blau H M., Brazelton T R., Weimann J M. The evolving concept of a stem cell: entity or function? Cell 2001 105 829-841
11. Comi G, Kappos L, Clanet M, et al. Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study Group. J Neurol 2000 247 376-382
12. Daniel D, Wegmann D R. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(923). Proc Natl Acad Sci USA 1996 93 956-960
13. DPT-1. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002 346 1685-1691
14. Ende N, Chen R, Mack R. NOD/LtJ type I diabetes in mice and the effect of stem cells (Berashis) derived from human umbilical cord blood. J Med 2002 33 181-187
15. Eizirik D L., Mandrup-Poulsen T. A choice of death the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 2001 44 2115-2133
16. Faria A MC, Weiner H L. Oral tolerance. Immunol Rev 2005 206 232-259
17. Fleischmann R M., Tesser J, Schiff M H., et al. Safety of extended treatment with Anakinra in patients with rheumatoid arthritis. Ann Rheum Dis 2006 65 1006-1012 (Pubitemid 44133261)
18. Fraser C K., Diener K R., Brown M P., Hayball J D. Improving vaccines by incorporating immunological coadjuvants. Expert Rev Vaccines 2007 6 559-578
19. Gale E A., Bingley P J., Emmett C L., Collier T. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 2004 363 925-931
20. Godfrey W R., Spoden D J., GE Y G., et al. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005 105 750-758
21. Haller M J., Viener H L., Wasserfall C, Brusko T, Atkinson M A., Schatz D A. Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol 2008 36 710-715
22. Harrison L C., Dempsey-Collier M, Kramer D R., Takahashi K. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp Med 1996 184 2167-2174
23. Hess D, et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003 21 763-770
24. Hummel M, Bonifacio E, Schmid S, Walter M, Knopff A, Ziegler A G. Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med 2004 140 882-886
25. Jansen F K., Muntefering H, Schmidt W A. Virus induced diabetes and the immune system. I. Suggestion that appearance of diabetes depends on immune reactions. Diabetologia 1977 13 545-549
26. Kent S C., Chen Y, Bregoli L, et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005 435 224-228
27. Kimpimaki T, Kulmala P, Savola K, et al. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 2002 87 4572-4579
28. Larsen C M., Faulenbach M, Vaag A, V lund A, Ehses J A., Seifert B, Mandrup-Poulsen T, Donath M Y. Interleukin-1-Rezeptor Antagonist in Type 2 Diabetes Mellitus. N Engl J Med 2007 356 1517-1526
29. Lechner A, et al. Bone marrow stem cells find a path to the pancreas. Nat Biotechnol 2003 21 755-756
30. Lennard A L., Jackson G H. Stem cell transplantation. BMJ 2000 321 433-437
31. Leslie R D., Atkinson M A., Notkins A L. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes. Diabetologia 1999 42 3-14
32. Ludvigsson J, Faresjö M, Hjorth M, et al. GAD treatment and Insulin secretion in recent-onset type 1 diabetes. N Engl J Med 2008 359 1909-1920
33. Maedler K, Sergeev P, Ris F, et al. Glucose-induced beta-cell-production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002 110 851-860
34. Maedler K, Sergeev P, Ehses J A., et al. Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets. Proc Natl Acad Sci USA 2004 101 8138-8143
35. Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello C A., Svenson M, Nielsen J H. Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia 1986 29 63-67
36. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 1996 39 1005-1029
37. Maron R, Guerau-de-Arellano M, Zhang X, Weiner H L. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse. J Autoimmun 2001 16 21-28
38. Mathis D, Vence L, Benoist C. -Cell death during progression to diabetes. Nature 2001 414 792-798
39. Mayer L, Shao L. Therapeutic potential of oral tolerance. Nat Rev Immunol 2004 4 407-419
40. Näntö-Salonen K, Kupila A, Simell S, et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 2008 372 1746-1755
41. Notkins A L., Lernmark A. Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 2001 108 1247-1252
42. Palmers J P., Fleming G A., Greenbaum C J., et al. C-Peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve -cell function: report of an ADA workshop, 2122 October 2001. Diabetes 2004 53 250-264
43. Pleau, et al. Prevention of autoimmune disease in nonobese diabetic female mice by treatment with recombinant glutamic acid decarboxylase (GAD65). Clin Immunol Pathol 1995 76 90-95
44. Schiff M H., Divittorio G, Fleischmann R M., et al. The safety of Anakinra in high-risk patients with active rheumatoid Arthritis six-month observations of patients with comorbid conditions. Arthritis & Rheumatism 2004 50 1752-1760
45. Skyler J S., Krischer J P., Wolfsdorf J, et al. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial-Typ 1. Diabetes Care 2005 28 1068-1076
46. Vardi P, Ziegler A G., Mathews J H., et al. Concentration of insulin autoantibodies at onset of type 1 diabetes. Inverse log-linear correlation with age. Diabetes Care 1988 11 736-739
47. Zhang Z J., Davidson L, Eisenbarth G, Weiner H L. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991 88 10252-10256
48. Ziegler A G., Hummel M, Schenker M, Bonifacio E. Antibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999 48 460-468